|Bid||0.2726 x 4000|
|Ask||0.2767 x 1000|
|Day's Range||0.2600 - 0.2700|
|52 Week Range||0.1700 - 1.8100|
|Beta (5Y Monthly)||-1.26|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.63|
Subscribe to Yahoo Finance Plus to view Fair Value for ATHX
Athersys Inc., the Cleveland-based regenerative medicine company, has hired turnaround specialist Ankura Consulting Group LLC and appointed the firm's senior managing director, Kasey Rosado, as its interim chief financial officer. Athersys lost its previous CFO, Ivor Macleod, in June through a restructuring — which included cutting its workforce by as much as 70% — aimed at reducing costs and making it an attractive investment for potential financial or strategic partners. New York-based Ankura offers management consulting and expert services "at critical inflection points," including corporate restructuring, bankruptcy, dispute and litigation, according to its LinkedIn page.
CLEVELAND, August 04, 2022--Athersys Appoints Kasey Rosado as Interim Chief Financial Officer - Brings Operational Excellence and Financial Experience to Leadership Team
Athersys leaders want to consolidate the company's shares to raise their trading price and increase the number of shares that could be issued in the future.